Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of 5-aza-2'-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells.
Momparler RL, Doré BT, Momparler LF. Momparler RL, et al. Among authors: momparler lf. Cancer Lett. 1990 Oct 8;54(1-2):21-8. doi: 10.1016/0304-3835(90)90086-d. Cancer Lett. 1990. PMID: 1698532
Inhibition of DNA and Histone Methylation by 5-Aza-2'-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells.
Momparler RL, Côté S, Momparler LF, Idaghdour Y. Momparler RL, et al. Among authors: momparler lf. Front Oncol. 2017 Feb 15;7:19. doi: 10.3389/fonc.2017.00019. eCollection 2017. Front Oncol. 2017. PMID: 28261562 Free PMC article.
Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation.
Momparler RL, Côté S, Momparler LF, Idaghdour Y. Momparler RL, et al. Among authors: momparler lf. Clin Epigenetics. 2014 Oct 1;6(1):19. doi: 10.1186/1868-7083-6-19. eCollection 2014. Clin Epigenetics. 2014. PMID: 25313314 Free PMC article.
Epigenetic action of decitabine (5-aza-2'-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C).
Momparler RL, Côté S, Momparler LF. Momparler RL, et al. Among authors: momparler lf. Leuk Res. 2013 Aug;37(8):980-4. doi: 10.1016/j.leukres.2013.04.019. Epub 2013 May 6. Leuk Res. 2013. PMID: 23660386
Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation.
Momparler RL, Idaghdour Y, Marquez VE, Momparler LF. Momparler RL, et al. Among authors: momparler lf. Leuk Res. 2012 Aug;36(8):1049-54. doi: 10.1016/j.leukres.2012.03.001. Epub 2012 Apr 1. Leuk Res. 2012. PMID: 22472464 Free article.
3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
Raynal NJ, Momparler LF, Rivard GE, Momparler RL. Raynal NJ, et al. Among authors: momparler lf. Leuk Res. 2011 Jan;35(1):110-8. doi: 10.1016/j.leukres.2010.04.014. Epub 2010 May 26. Leuk Res. 2011. PMID: 20510451
Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia.
Raynal NJ, Charbonneau M, Momparler LF, Momparler RL. Raynal NJ, et al. Among authors: momparler lf. Oncol Res. 2008;17(5):223-30. doi: 10.3727/096504008786111356. Oncol Res. 2008. PMID: 18980019
Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer.
Lemaire M, Chabot GG, Raynal NJ, Momparler LF, Hurtubise A, Bernstein ML, Momparler RL. Lemaire M, et al. Among authors: momparler lf. BMC Cancer. 2008 May 2;8:128. doi: 10.1186/1471-2407-8-128. BMC Cancer. 2008. PMID: 18454857 Free PMC article.
Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
Lemaire M, Momparler LF, Raynal NJ, Bernstein ML, Momparler RL. Lemaire M, et al. Among authors: momparler lf. Cancer Chemother Pharmacol. 2009 Feb;63(3):411-6. doi: 10.1007/s00280-008-0750-6. Epub 2008 Apr 9. Cancer Chemother Pharmacol. 2009. PMID: 18398609
Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia.
Lemaire M, Momparler LF, Bernstein ML, Marquez VE, Momparler RL. Lemaire M, et al. Among authors: momparler lf. Anticancer Drugs. 2005 Mar;16(3):301-8. doi: 10.1097/00001813-200503000-00009. Anticancer Drugs. 2005. PMID: 15711182
36 results
Jump to page
Feedback